Post by
MrMugsy on Mar 05, 2021 2:05pm
Quick Review of Development Products ...
Please forgive if incorrect ... product that still could be open ...
1. NeurAxon - NOS inhibitors for migraines - any IP or any work being done with NOS?
2. AzaSite - AKORN - bacterial Conjunctivitis
3. Protalix - bought 5% of company via GUD's Abir Therapeutics
4. Flexiseq - ProBono - pain and joint stiffness for OA, for Quebec and Israel
5. Crescita - dermo product - Carribean/Israel/Romania/Russia/S.Africa
6. Jaguar - Mytesi - anti-diarrheal
7. SIFI - Netildex - ocular inflammation
8. Probuphine - reimbursement for Ontario ????
9. 60P - Arakonda - Prevention of malaria
10. 60P family of products for other tropical diseases
Comment by
GoldenInvestor on Mar 05, 2021 2:47pm
Great Overview! Are those products for ex-Biotoscana?) Or can GBT also market some...$ If so, GUD has all those products set to come online & all the possibilities for S.A. lots of opportunity!
Comment by
Chianchin on Mar 05, 2021 3:36pm
No understand so many products but no profits? Than very bad MNGT
Comment by
MrMugsy on Mar 05, 2021 9:20pm
Try again Chian ... this time with your perfect english ... as we see you are capable of both. : )
Comment by
Benedict16th on Mar 06, 2021 9:18am
Anyone may google how Meir’s prediction were 100% correct about GUD future and how he fought for shareholder’s interest. As well how GUD’s proceeded to demonized Meir. It is all available on the internet.